ZH-BIO

ZH-BIO (Yantai Zhenghai Bio-Tech Co., Ltd.) was established in 2003 and successfully listed on May 16, 2017 (Stock Code: 300653). It is a key national R&D program undertaking unit, an "863" Program undertaking unit, and a high-tech enterprise. The company focuses on the field of regenerative medicine, which is a strategic priority industry in the "14th Five-Year Plan." It has obtained ISO13485/ISO9001 quality management system certification. ZH-BIO has set up high-standard regenerative medical materials R&D platforms, including the Shandong Provincial Engineering Technology Research Center for Medical Regenerative Repair Materials, the Shandong Provincial Enterprise Technology Center, and the Shandong Provincial Bioregenerative Materials Engineering Laboratory. The company emphasizes technological innovation with a rich pipeline of product development and significant competitive advantages. It has applied for more than 80 international and domestic patents, with core patents winning the First Prize of Shandong Patent Award and the China Patent Excellence Award. Based on its core decellularization technology, its products can achieve the function of regulating, guiding, and promoting the regeneration of human tissue cells. Its marketed products include oral repair membranes, absorbable dura mater (spinal) patches, skin repair membranes, bone repair materials, surgical packing sponges, and self-etching adhesives. These products are widely used in various clinical fields such as stomatology, head and neck surgery, neurosurgery, and otolaryngology, earning the trust and support of millions of doctors and patients. The company has undertaken more than 80 national and provincial and municipal scientific and technological development projects and has been approved for many honors such as the National Key R&D Program, the National "863" Program, the National Torch Program, the National Specialized, Professional, Unique, and Innovative "Little Giant" Enterprise, the National Intellectual Property Demonstration Enterprise, the Industrial Enterprise Intellectual Property Application Pilot Enterprise, the Shandong Province Independent Innovation Major Special Project, the Shandong Province Manufacturing Single Champion, the Shandong Province Technological Innovation Demonstration Enterprise, the Shandong Province Quality Benchmark Enterprise, the Top 50 Leading Enterprises in New Materials in Shandong Province, the Shandong Province Invisible Champion Enterprise, the Shandong Province Famous Brand, the Shandong Province High-Quality Brand, and various levels of technical invention awards and scientific progress awards. It is a director unit of the China Medical Device Industry Association and a model enterprise for implementing the Shandong Province Medical Device Production Quality Standards. Oriented towards meeting customer needs, the company's marketing network covers all provinces, autonomous regions, and municipalities in China. Adhering to the corporate vision of being "the leader in the field of regenerative medicine," ZH-BIO will make positive contributions to improving the quality of life of the people, enhancing social healthcare standards, and promoting the innovative development of the biopharmaceutical industry.